KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business Officer
KBI and Selexis welcome Abdelaziz Toumi, Ph.D., as Chief Business Officer. Toumi will lead Global Business Development for KBI and Selexis as well as the Program Management Office at KBI. Durham, North Carolina (October 31, 2022) -- KBI Biopharma,...
Read More